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A B ST R A C T

The purpose o f this study was to develop an effective and more sensitive
method for the determination o f lead in blood by graphite furnace atomic
absorption spectroscopy. Lead poisoning, and especially childhood lead
poisoning, is a major public health problem in many industrialized countries. The
presence o f lead in the blood is regarded as a reliable index to the extent o f recent
metal uptake. Therefore, the determination o f lead in blood is useful in the
diagnosis o f poisoning and in monitoring the working environment.
Sample pretreatment consisted o f a 1:2 dilution with a dilute surfactant.
To eliminate the background absorption signal from the blood matrix, a matrix
modifier solution o f 200 mg/L Pd and 2% citric acid in 0.01 mol/L nitric acid was
also deposited onto the furnace platform. In addition, an air atmosphere was used
during the pyrolysis step to aid in the combustion o f matrix materials.
Values for lead in the samples were obtained by direct comparison to a
linear working curve prepared from aqueous standards. An entire cycle could be
completed approximately every two minutes.
The determinations were performed in triplicate, and the relative standard
deviation was typically about 4% at low concentrations, indicative o f very good
precision. In addition, recoveries have ranged from 3 ppb to 50 ppb at low
concentrations o f blood lead. The limit o f detection was estimated to be 0.5-1
ppb.
The method proved to be rapid and simple, reliable and was reproducible.
In addition, there are minimal chances for contamination as the procedure does
not require the use o f many labwares and reagents. The only sample preparation
is the dilution, and thus the procedure lends itself to automation. The rapidity o f
the method and the requirement o f only tens o f microliter volumes o f blood
sample make the method potentially attractive for large-scale screening programs.

DETERMINATION OF TRACE LEVELS OF LEAD IN WHOLE BLOOD BY
GRAPHITE FURNACE
ATOMIC ABSORPTION SPECTROSCOPY

Chapter I: Introduction

Lead in the Environment
Lead is a heavy metal o f considerable utility and versatility, but is now a persistent
and ubiquitous environmental problem. It has been used at least since Biblical times in a
variety o f products, primarily in inorganic forms to the extent that its impact as an
environmental pollutant was o f little consequence until this century.(l,2,3) Lead pollution
has increased greatly due to its use, in metallic form, in storage batteries and in the past as
organic anti-knocking additives to petrol in the automotive industry.(1,3,4,5) It is estimated
that over seven million tons o f lead were burned in the United States between 1926 and
1985 through internal combustion engines, and it has been well documented that high
concentrations o f lead are found in surface soils o f even remote ecosystems as a result o f
atmospheric deposition.(3) Only during the last two to three decades have efforts been made
to recover lead from used batteries and to use alternative petrol additives.(l,2,4,6)
The health risks associated with exposure to lead are well recognized. There is now
sufficient evidence to indicate that exposure to even low lead levels (<100ug/L blood) can
produce adverse health effects, especially in more vulnerable segments o f the population;
including the unborn fetus, infants, children and the elderly.(7)

Important sources o f

exposure to environmental lead include paint, dust and soil in and around dwellings.(l,4,5,6)
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In addition, lead in drinking water arising from lead piping, fixtures, and lead-based solder
in household plumbing can also pose a significant risk.(l,4,5,6)
Chronic lead exposure is characterized by neurological defects, kidney dysfunction
and anemia.(2,3,6,8)

Neurological damage includes behavioral problems, intellectual

impairment and hyperactivity.(l,4,8,9) Various researchers have suggested that the most
controversial issue associated with the toxic effects o f lead exposure is in regard to subtle
behavioral effects due to moderately elevated lead levels.(l) Human behavior is influenced
by so many factors that the design o f studies taking these factors into account has been
extremely difficulty 1 )
Anatomic data suggest that the kidneys are the most sensitive to lead.(l,2,3,6)
Generalized aminoaciduria is a characteristic o f early lead nephropathy in both children and
aduhs.(l,2,3,6) In children with acute exposure to lead (blood lead levels o f at least 150
pg/dL), a complete renal Fanconi syndrome o f aminoaciduria, glycosureia and
hyperphosphaturia may develop.(3) The anemia o f chronic lead poisoning is known to be
due primarily to an inhibition o f the enzyme which controls the incorporation o f iron into
the heme molecule.(2,3,4,6)
Overall, the current understanding o f lead toxicity is considered inadequate,
particularly with respect to neurobehavioral effects in man, and in defining the magnitude
for maximum safe exposure levels.(l)

However, in the United States the Centers for

Disease Control has set the concentration o f blood lead (BPb) considered harmful. The
chosen value was recently lowered from 25 to 10 pg/dL (100ppb).(10)
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The assessment o f lead exposures from paint, dust, soil, food and drinking water
requires the reliable determination o f lead in clinical samples. As a result, projects
committed to the standardization o f sampling, sample preparation, and analysis o f lead in
whole blood are a critical part o f lead poisoning prevention.(7,ll) The most common
analytical technique for the determination o f trace levels o f lead in blood is through graphite
furnace atomic absorption, as it requires only tens o f microliters o f sample and can provide
detection limits up to

1 0 0

times

lower than other conventional

spectroscopic

techniques.( 12,13)

Comparison of Spectroscopic Analytical Methods
A variety o f analytical methods have been used for the determination o f lead in
biological samples. Spectroscopic techniques include: inductively coupled plasma mass
spectroscopy, inductively coupled plasma atomic emission spectroscopy, and flame and
graphite furnace atomic absorption spectroscopy.

Each o f these methods will be

described briefly.

Inductively Coupled Plasm a Mass Spectroscopy (ICP-MS). ICP-MS is an efficient
technique with low detection limits (ng/L range) and rapid sample throughput; however,
instrumentation is expensive (>$100,000). An argon plasma is used as the ion source for
a quadrupole mass spectrometer.(14) Spectral interferences do not occur in the normal
sense o f ICP, but interferences from mass overlaps due to other elemental isotopes and
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polyatomic species produced in the plasma can occur.(14)

These interferences may

provide erroneous results, but can be reduced with high resolution instrumentation^ 14)
ICP-MS has proven to be a powerful technique for the determination o f trace
metals in various matrices.(13,14,15) Trace metal determination in biological matrices,
however, can be very time consuming and tedious. Salts must be removed from high salt
matrices before analysis due to interferences from mass overlaps.(14) Interferences may
be corrected for by procedures such as principle component analysis or isotope
dilution.(14) Salts are usually removed by chemical separation procedures, such as a
solvent extraction procedure, which may introduce error and thus offset analytical
advantages.( 13,14,15)

Inductively Coupled Plasm a Atomic Emission Spectroscopy (ICP-AES). ICP-AES
is the most widely accepted and utilized multielement atomic spectroscopy technique, as
it can detect selected elements simultaneously or sequentially.(13,14,15) By monitoring
selected analytical emission wavelengths for each element, either all at once or in a
programmed sequence, many elements in a given sample can be determined in one
automated analysis.(13,14,15) In addition, ICP-AES has an analytical working range o f
up to six orders o f magnitude.(13,14,15) This broad linear dynamic range enables the
determination o f samples with widely varying concentrations. The detection limit (about
20 fig/L) is the primary problem for the determination o f lead in blood.(15)
inadequate for routine determinations.

It is
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The determination o f trace metals in biological samples by ICP-AES typically
requires a separation o f the analyte from the matrix because high concentrations o f salts
in these samples tend to clog the sample orifice o f the ICP torch.(14,15) This separation
is time-consuming and can create difficulties in creating analytical blanks and in
controlling contamination problems.

Flame Atomic Absorption Spectroscopy

(FAAS).

FAAS is a simple, rapid and

precise method for trace metal analysis; however, large sample volumes are required and
the limit o f detection for lead (40-50 pg/L) is insufficient for trace analysis.(13) The
typical analytical working range is two to three orders o f magnitude^ 14) For the analysis
o f higher concentrations o f lead, FAAS may be the instrument o f choice.

The

determination o f lead at pg/L concentrations and below requires the use o f
preconcentration techniques, which are very tedious and time-consuming.(13,14)
Preconcentration can be accomplished by several methods such as liquid-liquid extraction
with

an

organic

phase,

ion

exchange

preconcentration,

co-precipitation,

and

electrochemical methods. However, any preconcentration technique is slow and prone to
contamination.

G raphite Furnace Atomic A bsorption Spectroscopy

(GFAAS).

By far the most

advanced and highly sensitive atomization method for atomic absorption is the graphite
furnace. The limit o f detection for lead analysis by GFAAS is at least ten times better
than FAAS; however, GFAAS has a limited analytical working range o f a little over two
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orders o f magnitude.(13,14) A single routine GFAAS determination for a single element
normally requires two to three minutes due to the multiple step temperature program
required. Only small sample volumes are required, which is particularly useful in the
analysis o f biological samples. Matrix interferences can be controlled, in most cases,
without the incorporation o f extraction and preconcentration techniques. Thus, GFAAS
appears to be the most useful o f the existing analytical methods for the determination o f
trace levels o f lead in small biological sample volumes; however, many GFAAS systems
with low limits o f detection and good precision and reproducibility require the use o f the
costly Zeeman background correction systems and electrodeless discharge lamps.
Further improvement in the methodologies could allow for improved simplicity and
sensitivity for the technique.

This would make GFAAS methods more attractive for

routine lead screening programs using automated systems with sufficiently low limits o f
detection and no sample pretreatment steps, other than simple dilution, with more
accessible GFAAS instrumentation.

Chapter II:
Graphite Furnace Atomic Absorption Spectroscopy

Introduction
GFAAS is a routine analytical method for the quantification o f many elements in a
variety o f sample matrices.

In order to understand this analytical technique, a brief

description o f the theory behind atomic absorption and o f the components o f the graphite
furnace are necessary.
In atomic absorption, a liquid sample is typically reduced to atoms at elevated
temperatures as a narrow band o f electromagnetic radiation, typically in the ultraviolet
through the visible region o f the spectrum, is passed through the sample.(12,13,16,17) The
ground state o f the atom absorbs light energy o f a specific wavelength and, through
electronic transitions, the atom enters the excited state as illustrated in Figure 1.

+

L ig h t
E n e rg y

Ground
State
A tom

E x cited
State
Atom

Figure 1: The process of atomic absorption. Ref. 16
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The amount o f light absorbed is directly proportional to the number o f atoms in the
beam. A quantitative determination o f the amount o f analyte can be made by measuring the
amount

of

light

absorbed

relative

to

known

concentrations

o f the

analyte

elemental2,13,16,17) Through the use o f light sources specific to the given element and
carefully chosen wavelengths, the selective determination o f individual elements is achieved
such that spectral interferences from other species are minimized.
The intensity o f the incident radiation from the radiation source (Io) decreases after it
passes through the gaseous atoms.(12,13,16,17) The remaining intensity (I) is given by the
transmittance (T), where
T = I/Io.
The transmittance can then be related to the absorbance (A) by Beer's Law, which states
A = - log T = abc
where ‘a’ is the absorptivity coefficient for the absorbing species, 4 b’ is the thickness o f the
sample cell (usually measured in centimeters), and ‘c’ is the concentration o f the absorbing
species.

Thus, the extent o f absorption depends primarily on the concentration o f the

absorbing species since in practice the length o f the sample cell is held constant. Absorption
as a function o f concentration should be linear over a range o f analyte concentrations
measured in the same sample matrix.
At sufficiently high concentrations most elements tend to deviate from Beer's Law in
that the relationship between concentration and absorbance is no longer linear. There are
many reasons for this, including nonhomogeneous temperatures in the absorbing cell, stray
light, line broadening and self-absorption. ( 12,13,16,17)

In order to correct for this,
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microprocessors are incorporated into modem atomic absorption instruments which plot
absorbance vs. concentration curves over a wide range o f concentrations. The instrument
then utilizes an automatic curve correction to determine elemental content when sample
concentrations are beyond the linear range.

Instrumentation
Conventional models incorporate at least the following five instrumental
components: a lamp as a source o f electromagnetic radiation, a graphite tube as a sample
cell in which atoms are produced, a monochromator for wavelength isolation, a detector
which measures the light intensity and amplifies the signal, and a microprocessor system
that will electronically interpret the signal.(12,13,16,17) A system to correct for background
spectral interferences is usually incorporated as well. A schematic diagram o f a typical
GFAA instrument is shown in Figure 2.

Sc-ecL'ic L i^ht M fix a u rsn ien t

S cu rce

Mco cchr cn: a:or

Figure 2: Schematic diagram of atomic absorption spectrophotometer. Ref.16
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The light source that is typically used is a hollow cathode lamp (HCL), which
produces a bright, stable and long-lived radiation source.(12,13,16,17) The energy required
for atomization is provided by applying a high voltage electrical current through the graphite
tube where the sample has been placed. A programmable power supply provides precise
control o f temperature programs in the atomization process. The atomic vapor generated
from the furnace can absorb light. The light is electronically modulated to differentiate
between the light from the source and emission from the sample cell. The monochromator
is used to isolate a specific wavelength for detection by a photomultiplier tube. An electrical
current is then produced and processed depending on the intensity o f the light reaching the
detector. A time-dependent signal is produced and either peak height or peak area can be
measured and compared to a calibration curve in order to determine the analyte
concentration.
Since atoms absorb light at very specific wavelengths, it is necessary to use a lamp
that will provide the narrow-line spectra o f the element o f interest. The hollow cathode
lamp is a bright, stable source for most elements.(12,13,16,17) Figure 3 illustrates how a
hollow cathode lamp is constructed. The lamp consists o f a tungsten anode and a cylindrical
cathode sealed in a glass tube filled with neon or argon. The cathode is constructed entirely
or in part of the metal whose spectrum is to be produced. Ionization o f the inert gas occurs
when a potential on the order o f 300 V is applied across the electrodes, and a current ranging
from 5 to 20 mA is generated as ions and electrons migrate to these electrodes. If the
potential is sufficiently large, a process called "sputtering" occurs in which the gaseous
cations acquire enough kinetic energy to dislodge some o f the metal atoms from the cathode
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surface, thus forming an atomic cloud. These sputtered metal atoms are produced in excited
states and they emit characteristic radiation in returning to the ground state. Eventually, the
metal atoms are redeposited as they diffuse back to the cathode or to the glass walls.

NEON OR ARGON

ANODE
OPEN
SHIELD

CATHODE

O

Figure 3: Diagram of a hollow cathode lamp. Ref.16

The sample cell consists o f an electrically heated graphite tube into which the
sample is deposited.(12,13,16,17) The graphite furnace, shown in Figure 4, is heated by
applying a high current across the water cooled graphite contacts to resistively heat the
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graphite tube for sample volatilization. The dimensions o f the graphite tube have been
optimized, as the absorbance signal is dependent, among other variables, upon the residence
time o f the atoms in the sample tube.(10,16)

Larger tubes tend to heat slowly and

problematic temperature gradients along the tube length develop. Shorter tubes heat rapidly
to the extent that the sample residence time would be too short.

Internal External
Gas Flow Gas Row

Window Assy

External Internal
Row Gas Flow

^ Graphite
S Cooling
\ Ring
7777!

Light Beam
lim illllllllllllU tfilllU lllU tllU I I I J I I I

Graphite
> Contacts
External
Gas Row

External
Gas Row

Figure 4: Cross-section of a graphite furnace. Ref. 12

Normal graphite has a relatively coarse, layered surface which allows certain
materials and elements to penetrate into the lattice where they can interact with the graphite
at elevated temperatures.(12,16,17) This can pose problems because the analyte may be
retained by the graphite and released only at higher temperatures. Thus, graphite tubes are
commonly coated with pyrolytic graphite to make the tubes more impervious to metals in
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the vapor phase. Pyrolytically coated graphite tubes have a more uniform and dense surface
that does not allow for sample or solvent penetration, and they are thus more chemically
inert.
When wall atomization is used, the sample is deposited onto the wall in the center o f
the tube.(12,16,17) This is the area o f the tube that is heated most rapidly and which reaches
the atomization temperature first. Thus, the analyte is volatilized off o f the wall into an
environment which is cooler than the surface from which it was volatilized. This leads to
conditions that are very difficult to control and which can cause various matrix
interferences.
In order to achieve atomization and volatilization at a more constant temperature
throughout the tube, the sample is often atomized from a small platform o f solid pyrolytic
graphite inserted into the tube.(12,16,17) An illustration o f a L’vov platform inserted in a
graphite tube is shown in Figure 5. The graphite tube is heated primarily by an electric
current passing through it; however, the platform is heated primarily by radiation from the
tube walls. Therefore, there is a time lag between the heating o f the tube and the platform,
which serves to delay the atomization o f the sample until the graphite tube and the inert gas
reach thermal equilibrium. The L'vov platform has a proven reputation for providing greater
control and reproducibility o f the atomization conditions, and for reductions in sample
matrix interferences.
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GRAPHITE TUBE
( Portion of Side Cut A w a y )

PLATFORM
( I n s e r t ' d in T u b e )

END VIEW

Figure 5: L ’vov platform inserted in a graphite tube. Ref. 12

The graphite tube is completely enclosed in order to minimize environmental
influences, except for the port through which the sample is deposited.(12,13,16,17)
Removable quartz windows are located at both ends of the furnace to allow for passage o f
the HCL beam. Two independently controlled gas flows are used. An external flow o f an
inert gas protects the tube from ambient air exposure, which would cause degradation at
high temperatures due to oxygen. Because an inert atmosphere during atomization is a
prerequisite for any graphite furnace analysis, an internal gas flow is also used both before
and after atomization. This gas protects the hot graphite from burning away through contact
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with the ambient air and serves to purge the tube o f any matrix materials volatilized during
the pre-atomization dry and char steps. After atomization, the inert flow also serves to flush
the tube o f any remaining materials from the sample. Argon is typically used for both the
external protective and the internal purge gas, as it does not react with the graphite or with
analyte atoms.
Alternate gases can be used during the thermal char o f samples with complex
matrices, such as in the atomization o f biological samples.(12,16,17) The use o f air as a
purge gas during the pyrolysis step can provide a much more effective char and thus a more
complete removal o f organic and biological materials, which may otherwise cause a carbon
buildup on the inside o f the tube and interfere with the analysis.
Graphite tubes typically have lifetimes o f 50 to 300 determinations, depending on
atomization rate, temperature, the rate o f gas flow, and the composition o f the sample
matrix.(12,16,17) As the tube ages, analytical precision will decrease. The use o f a L'vov
platform typically results in a longer tube lifetime as the sample does not come into direct
contact with the tube wall.

In order to achieve the maximum useful tube lifetime the

atomization temperature and time should be kept as low as possible. As the tube ages, the
analytical peak may change in shape and the tube should typically be replaced when the
absorbance value drops to about 20% below the original value.
Graphite furnace atomic absorption spectroscopy is not rapid due to the long interval
between individual firings (2-3 minutes). Automatic samplers are almost a necessity for
precise volume measurements and the reproducible deposition o f samples into the graphite
tubes. The manual deposition o f a small volume o f liquid into a small, dark sample opening
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is very difficult and requires substantial analytical expertise.

Furthermore, not only

accurately dispensed volumes, but also the position o f the sample droplet in the graphite
tube has an influence on the precision o f the resuhs.(12,16,17)

Interferences
Interferences in graphite furnace atomic absorption are evidenced by either an
enhancement or depression o f the absorbance signal when compared to an appropriate
standard at the same concentration^ 12,16,17) Various categories o f interferences exist in
atomic absorption; these are chemical interferences, ionization interferences, emission
interferences, spectral interferences and background absorption.
Chemical interferences result when the sample contains thermally stable compounds
of the element o f interest which do not decompose at the prescribed furnace
temperatures.(12,16,l 7) As a result, the number o f analyte atoms in the vapor phase capable
of absorbing light is reduced. These interferences can usually be overcome with the use o f a
higher atomization temperature, or through the use of chemical matrix modification.
Increased atomization temperatures provide additional energy to break down the compounds
that are stable at the lower temperature; however, more volatile elemental species may be
lost in the process. Releasing agents or complexing cations can be added to preferentially
react with the interferent to release the analyte at lower temperatures and indirectly remove
the chemical interference.
Ionization interferences result when the furnace temperature has enough energy to
cause the removal o f an electron from the atom, thus creating an ion.(12,16,17) This also
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reduces the number o f atoms in the ground state; and thus the extent o f atomic absorption is
reduced. In order to minimize this type o f interference, an excess o f an easily ionized
element can be added to both the standards and samples. Alternatively, a lower atomization
temperature may be used; however, this may create other potential interferences.
The major emission

interferences in graphite

furnace

atomic

absorption

spectroscopy are due to black body radiation from the furnace tube or from highly emissive
species in the sample.(12,16,17)

At low analyte concentrations, the atomic absorption

analysis may exhibit poor precision if the emission signal falls within the spectral bandpass
being used. This radiation is evidenced by increased noise or, occasionally, by baseline
shifts.

The emission signal is generally due to emission from the carbon tube itself;

however, materials in the furnace or sample may also emit radiation. The slit width o f the
monochromator may be decreased in order to somewhat compensate for this interference,
resulting in some loss o f sensitivity.
Spectral interferences result when an absorbing wavelength o f a species present in
the sample falls within the bandwidth o f the absorption line of the element o f
interest.(12,16,17) In this case, analytical results will be erroneously high as the interfering
element will augment the atomic absorption signal. A smaller slit width may be used or an
alternate wavelength chosen to correct for spectral interferences.
Background absorption is a common interference in atomic absorption for which
there are two primary sources: light scattering by particles in the vapor phase and molecular
absorption o f light by molecules in the vapor phase.(12,16,17) Some samples, especially
biological samples, may absorb or scatter light from the source due to the existence o f
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gaseous molecular species or salts in the vapor phase at the atomization temperature. In
addition, the radiation from a continuum source used to measure background absorption
may be absorbed by species from the matrix if they have an absorption line within the
spectral bandpass being used for the analysis.

Fortunately, low levels o f background

absorption can be distinguished from the absorption o f the element o f interest. The analyte
element will only absorb the narrow line emitted by the source lamp; whereas background
absorption is less specific and extends over a broad band o f wavelengths.
The most common way to compensate for background absorption is through
background correction, which subtracts non-analyte absorption signals from the total
absorbance signal generated.

The deuterium arc lamp continuum source background

corrector, which is the most commonly used system for background correction, is designed
to automatically correct for broad-band nonatomic absorption in the UV region from 195
nm to 320 nm.( 12,13,16,17) The lamp, which is adjusted to equal intensity with the primary
source, emits light over a broad spectrum o f wavelengths instead o f specific lines. The
hollow cathode lamp and light from this continuum source are passed alternately through the
furnace. The element being determined absorbs only the discrete lines from the hollow
cathode lamp while background interferences can absorb light over the bandwidth o f the slit.
The overall bandwidth (typically 0.2-0.7 nm) is quite large compared to the linewidth o f the
atomic transition (0.001-0.0001 nm).

Thus, there is negligible error in the background

correction. Finally, the difference in the two beam intensities is measured electronically and
used to eliminate the effect o f the background absorption.
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Background correction with a continuum radiation source is limited in that it only
accurately corrects for background absorption that is constant in intensity over the observed
spectral bandwidth.( 12,16,17) When the background absorption changes with wavelength
the continuum source background corrector will subtract the average background signal,
which may not be identical to the actual background absorption on the resonance line and
results in overcompensation. Any baseline offset in the vicinity o f the absorption signal or
any over-compensation o f the background is a clear indication o f improper background
correction. In order to prevent this, other background correction systems may be used, such
as Zeeman or Smith-Hjeifte systems; however, these systems are far more costly.
Background absorption can also be reduced through several alternative means.
Matrix modification through the addition o f other species to the sample will frequently
reduce the effects o f background absorption. Alternatively, one can reduce the sample size
by injecting less or by diluting the sample.

Increasing the temperatures o f the pre

atomization steps may also reduce background absorption, particularly if the background
signal is being produced by a volatile organic matrix constituent. One may also increase the
flow rate o f the purge gas in order to decrease the residence time o f the backgroundproducing constituents in the furnace. Unfortunately, these alternatives also often result in
poorer limits o f detection.

Optimization of Analytical Methods
In graphite furnace atomic absorption, the desolvation o f the sample, dissociation
from the matrix, and the generation o f analyte ground state atoms occur sequentially during
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the dry, char, and atomization steps respectively.

Thus, it is necessary to select the

individual temperatures such that each step is effectively carried out for its intended
purpose.( 12,16,17)
In creating the temperature program, temperature ramping allows a controlled,
gradual increase in the furnace temperature instead o f a strictly stepwise procedure.
Stepwise procedures may be inadequate because the thermal treatment at any particular step
/

may be incomplete; thus causing the more volatile constituents of the matrix to dissociate,
melt or rapidly boil when the temperature program abruptly advances to the next
step.(12,16,17) This sample spattering may lead to poor precision and loss o f sample. By
using temperature ramping, each o f the constituents in a complex biological sample may be
more effectively decomposed.
The purpose o f all pre-atomization steps is to decompose and remove all matrix
materials as thoroughly as possible so that the atomization o f the analyte element can be
carried out with minimal interferences.(12,16,17) The temperatures for these steps must be
carefully chosen as they need to be long enough and the temperature high enough to
completely volatilize any particulate-producing or interfering compounds. The purpose o f
the dry step is to evaporate low boiling liquids from the sample while the char step is used to
remove as much o f the matrix as possible before atomization. The physical properties o f all
materials and compounds present in the sample matrix largely determine the success o f this
separation. Thus, the thermal stability o f the matrix in which the analyte element o f interest
resides is o f major significance. The more volatile the matrix materials and the less volatile
the analyte element, the easier the separation. Thus, the addition o f matrix modifiers can
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chemically convert the analyte to a less volatile form, or the matrix into a more volatile
form.
Matrix modification has been proposed as a technique to transform elements into a
more well defined compound with known properties in graphite furnace applications. This
provides for the use o f optimal temperature conditions for the thermal pretreatment o f the
matrix.(12,16,17)

Higher pretreatment temperatures ensure the best separation o f the

analyte from accompanying materials, and thus reduces the chance o f encountering
background interferences. Matrix modification may also help to avoid the appearance o f
multiple analyte peaks in the absorption profile due to the absorption o f different
compounds o f the analyte element present in the original sample that are volatilized at
different temperatures.
The temperature selected for atomization must be high enough to completely
volatilize the analyte element within a few seconds without loss o f analyte.(12,16,17) The
atomization time is chosen to be as short as possible while still allowing for the complete
volatilization o f the analyte element. If this time is too short, some o f the analyte may be
retained in the furnace, thus causing erroneous results for the following samples.
The external protective gas stream around the tube is normally fixed.(12,16,17) The
purge gas stream, however, must be precisely controlled such that it completely removes all
volatilized material from the tube without allowing it to recondense in cooler areas o f the
furnace. During atomization, however, the purge gas is stopped so that the analyte atoms
are kept in the beam o f radiation as long as possible in order to give the highest absorbance.

Chapter IK:
The Determination o f Lead in Blood via GFAAS

Among the various techniques used for the determination o f lead in blood,
electrothermal atomic absorption spectroscopy (ETAAS) is very popular because o f the
excellent sensitivity and selectivity for lead.(18)

Numerous methodologies have been

published for ETAAS with wide variations in atomization, sample pre-treatments and
analytical methods. Most methods involve simple dilution o f the blood, normally with a
haemolysing agent such as Triton X-100, and then introduction into the furnace for drying,
ashing, and subsequent atomization. The main problem encountered in the application o f
electrothermal atomization to volatile analytes in samples containing appreciable amounts o f
organic matter is obtaining satisfactory separation o f the ash and atomization signals. This
separation is necessary, even if a background correction system is employed, in order to
obtain reliable resuhs.(12,16,17)

Thus, numerous groups have developed methods to

remove the organic interferences either by chemical modification o f the matrix or through
the use o f an oxygen pre-ash to aid in the combustion o f interfering species.
Eaton and Holcombe published a comparative study which evaluated various
matrix modifiers and procedures.(18) In particular, the roles o f O 2 ashing, Triton X-100,
HNO3 and NH4H2PO4 were studied. The group suggested a method for the determination
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o f lead in human whole blood using GFAAS.

As previously described, the use of

temperature ramping allows for a more controlled, gradual increase in the furnace
temperature; whereas a strictly stepwise procedure as performed here can cause the more
volatile constituents o f the matrix to dissociate, melt or rapidly boil when the temperature
program abruptly advances to the next step.(12,16,17) The temperature program used in
this study is provided in Table 1.

Step

Dry
Char
Atomization
Cool-down

Furnace
Temperature
(°C)
100
900
2000
25

Ramp
Time
(s)
0
0
0
0

Hold
(s)
45
45
3-5
25

Internal
Gas Flow
(mL/min)
200
200*
200
200

’•'Denotes the alternate gas, air.
Table 1: Temperature program for the study done by Eaton and Holcombe

The method did not utilize a continuum background correction system, thus the
reduction o f spectral interferences was a primary concern. The high salt concentration o f
blood was reduced by using red cells rather than whole blood, as previous research has
clearly shown that lead tends to adsorb on the surface o f red cells. Sample preparation
involved centrifugation o f the blood in order to isolate the whole red cells from the blood
plasma.

This, however, can be tedious, timely and can introduce sampling errors and

contamination.
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Background measurements were made with the 280.3nm line o f lead.(18)

Ash

buildup was noted after several firings which was difficult to remove even with a high
temperature burnout in the inert sheath gas. Thus, an air ashing was used to remove the
carbonaceous deposits. Air, which is approximately 20% O2 , was used at 2.0 L/min during
the dry and first ash step o f the temperature program. In the absence o f air a maximum ash
temperature o f 500° C could be utilized without a significant loss o f lead; however, in the
presence o f air ash temperatures o f up to 950 °C were used.

This temperature was

sufficient to ensure combustion o f the matrix without analyte loss. The group suggested
that 0 2 was adsorbed as a surface oxide on the graphite and desorbed as CO. The CO
was only released at an appreciable rate at elevated temperatures o f greater than 1000° C.
Thus, only a few monolayers o f the graphite were removed on every firing as long as an
inert atmosphere existed within the furnace at temperatures greater than 1000° C.
The study also confirmed the utility o f Triton X-100 in blood analysis.( 18) This
surfactant reduced the sample/graphite interfacial tension and allowed improved contact
between the sample and the furnace walls. Without the addition o f the Triton X-100, the
majority o f the sample was physically lost from the furnace due to frothing during the
dry, and the subsequent ashing was ineffective due to poor contact with the graphite tube.
Several concentrations o f Triton X-100 were used, ranging from 0.1 to 5.0% (v/v). At
higher concentrations, interfacial tension was so reduced that the sample flowed out o f
the ends o f the graphite tube resulting in a loss o f signal.
Many studies have indicated that the addition o f low concentrations o f HNO3 will
stabilize aqueous solutions o f lead standards and prevent adsorption o f the metal onto the
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storage container walls. However, this study determined that significant variations in
peak heights and areas caused by minor changes in acid concentrations outweighed the
benefits o f its use.

Many researchers have also added phosphate salts, such as

NH 4 H 2 PO 4 , as matrix modifiers to facilitate the determination o f lead in blood. However,
the study also indicated that the addition o f phosphate salts to whole blood and whole red
cells resulted in considerably higher background absorbances.

The addition o f

NH 4 H 2 PO 4 to aqueous lead standards and blood samples also allowed for higher
temperatures to acquire the absorbance peak; however, no explanation for this
phenomenon was postulated.
Fernandez also developed a method for lead determinations in whole blood by
GFAA in which no matrix modifiers were used, other than a simple fivefold dilution o f
the blood with 0.01% Triton X-100 surfactant.(19) When the samples were diluted with
de-ionized water, an appreciable buildup o f residue from the blood matrix was observed
in the tube, making the use o f simple aqueous dilution impractical. Hemolysis o f the
blood by dilution with the diluent eliminated this residue buildup problem. The use o f
various dilution ratios was investigated, and it was found that a fivefold sample dilution
provided the best compromise between adequate sensitivity and low background
absorption.

To eliminate the nonspecific absorption signal from the blood matrix, a

deuterium arc background correction system was used.
The procedure recommended by Fernandez was problematic for the same reasons as
was the aforementioned procedure. The temperature program provided below in Table 2
was suggested as optimum; however, it did not include the use o f temperature ramps. In
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addition, the char temperature was very low, and thus may not have removed all potential
interferences.

Step

Diy
Char
Atomization

Furnace
Temperature
(°C)
100
525
2300

Ramp
Time
(s)
0
0
0

Hold
(»>
25
50
9

Internal
Gas Flow
(mL/min)
15
15
15

Table 2: Temperature program for the study done by Fernandez

The average recovery was studied by adding known amounts o f lead nitrate to
several blood samples. This recovery was typically around 98% over a concentration
range o f 150-1000 pg/L with precisions ranging from 2-4%. However, this concentration
range is not a realistic range to study as the Centers for Disease Control recently lowered
the concentration o f blood lead considered harmful to young children from 250 to 100
pg/L. Thus, a routine method for pediatric screening must be able to accurately and
precisely detect blood lead levels lower than 100 pg/L. In addition, this method involved
a centrifugation procedure to mix the diluted blood samples, which was tedious and can
lead to contamination and transfer error.
Fernandez and Hilligoss developed a different method for the determination o f
lead in blood using the graphite fumace.(20)

However, the paper was short and

inconclusive, and no limit o f detection was mentioned. The method involved a fivefold
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dilution o f blood in 0.5% Triton-X 100, matrix modification with 0.2% NH 4 H 2 PO 4 ,
deuterium arc background correction and utilization o f the L’vov platform.
In contrast to the findings o f Eaton and Holcombe, the results o f this study
indicated that the use o f NH4H2PO4 virtually eliminated any background interferences
and residue buildup from the blood matrix, thus significantly extending the lifetime o f the
graphite tube.(lO) However, this discrepancy may be due to the fact that this group
utilized whole blood whereas Eaton and Holcombe used only red cells.

Thus, these

results indicated that phosphate salts might be o f some utility in reducing salt
interferences when using complex biological samples such as whole blood.

Step

Dry
Dry II
Char
Atomization
Cleanout

Furnace
Temperature
(°C)
130
200
600
1700
2500

Ramp
Time
(s)
10
15
15
0
1

Hold
(s)
5
20
45
6
4

Internal
Gas Flow
(mL/min)
0
0
0
40
0

Table 3: Temperature program for the study done by Fernandez and Hilligoss

The prescribed temperature program shown in Table 3 was more typical than the
one previously suggested by Fernandez, as it included the use o f temperature ramps and
cleanout; however, the suggested char temperature was low.

In addition, the study

suggested the use o f an internal argon flow during atomization, but this purge gas was not
used for any other step. Ordinarily, the purge gas is used to force some o f the vaporized
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matrix materials and burned organic residue out o f the furnace prior to atomization and
during the cleanout. The use o f the purge gas during atomization; however, may have
forced some o f the lead atoms out o f the furnace and attenuated the signal. The samples
were also noted to rapidly clot and suspend particulate matter, which noticeably degraded
both precision and accuracy.
Pruszkowska, Camrick and Slavin also suggested a procedure for the
determination o f lead in blood using a combined modifier containing

0

.2 % NH 4 H 2 PO4

and 0.05% Mg(NO)3 .(2 1 ) In addition, 1% HNO 3 was added to the solution in order to
prevent the precipitation o f magnesium phosphate.
This procedure involved a two step deposition o f the samples onto the L ’vov
platform. First, a 10 pL aliquot o f the blood sample diluted 10-fold in de-ionized water
containing 0.2% Triton X-100 was automatically dispensed onto the platform using an
autosampler.

A 5 pL aliquot o f the modifier solution was then added on top o f the

previously deposited samples and standards. The temperature program was typical for
the determination o f lead in blood, as given in Table 4.

Step

Dry
Char
Atomization
Cleanout
Cool-down

Furnace
Temperature
(°C)
130
650
1700
2600
20

Ramp
Time
(s)
1
1
0
1
1

Hold
(s)
60
45
5
6
20

Internal
Gas Flow
(mL/min)
300
300
0
300
300

Table 4: Temperature Program used for the study done by Pruszkowska, Carnrick
and Slavin

30

The use o f this method, along with a magnetic Zeeman background correction
system and an electrodeless discharge lamp running at 10 Watts, enabled the group to
reach a sensitive limit o f detection o f 10 pg/L. In addition, a 93-101% recovery was
reported, and the results were in good agreement with those from the Yale-New Haven
Hospital, which also analyzed the lead content o f the samples. The reported precision
was better than 2.5% at levels o f 200 pg/L.
One problem that was noted involved the appearance o f a small, early-running
peak in the blood which was perhaps due to the absorbance o f lead volatilized as the
chloride. In addition, this method has proven to be impractical for reproduction when
used with the more accessible and less costly deuterium arc background correction
system due to the appearance o f high background signals and suppressed analyte signals.
Slavin and Parsons developed a different method for the determination o f lead in
blood via graphite furnace atomic absorption which was more rapid than any o f the others
previously described.(17)

This method, with Zeeman background correction, again

cannot be easily replicated using a deuterium arc background correction system. Whole
blood was diluted 1:10 in a phosphate modifier containing 0.2% NH4H2PO4, 0.5% Triton
X-100 and dilute nitric acid with sampling on a L ’vov platform. Except for the small
purge gas flow during atomization the temperature program was typical as shown in
Table 5.
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Step

Dry
Dry II
C har
Atomization
Cleanout

Furnace
Tem perature
(°C)
175
260
900
1900
2500

Ramp
Time
00
5
5
5
1
1

Hold
00
10
10
2 0
5
2

Internal
Gas Flow
(mL/min)
300
300
300
30
300

Table 5: T em perature program used in the study done by Slavin and Parsons

An entire cycle was completed every 115 seconds with standard deviations
typically about 2.5 pg/L at concentrations o f 100 pg/L, indicative o f very good precision.
The method appeared to be rugged and reliable as well as precise and accurate, as it
rapidly determined concentrations down to 10 pg/L.
Hodges and Skelding described a method for the determination o f lead in blood
by atomic absorption spectroscopy with electrothermal atomization using a very unique
matrix modification technique.(22) The method proposed a matrix modification solution
comprised o f 1% orthophosphoric acid, 1% HNO3, and 0.1% Triton X-100. In addition,
a pre-coating o f the graphite tube with molybdenum was suggested in order to most
effectively minimize matrix interferences and to promote stable routine operation.
The addition o f the orthophosphoric acid was effective in raising the atomization
temperature o f lead, thereby allowing greater time resolution o f the ash and atomization
processes. The lowest temperature at which atomization was detectable was reportedly
increased from 630 to 840° C in the presence o f the orthophosphoric acid.

It was

proposed that the substitution o f more volatile anions by orthophosphate was beneficial in
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minimizing if not eliminating the interference o f halide and sulfate salts. The role of
molybdenum as a coating for carbon tubes was not clear; however, it was postulated that
the coating played some part in modifying the matrix so that background absorption due
to phosphate salts was reduced. Overall, the molybdenum-coated tubes appeared to allow
more reproducible analyte absorption signals to be obtained from the various blood
samples.
The temperature program did not include the use o f temperature ramps between
steps or a step for the HGA cleanout. In addition, no internal purge gas was mentioned.
The temperature program is shown in Table 6 below.

Step

Dry
Char
Atomization

Furnace
Temperature
(°C)
100
750
2500

Ramp
Time
(s)
0
0
0

Hold
(s)
60
30
2-5

Internal
Gas Flow
(mL/min)
0
0
0

Table 6: Temperature Program used for the study done by Hodges and Skelding

Over the extended study the method appeared to be reliable and it exhibited consistently
good performance in regards to both precision and accuracy. The limit o f detection was
50 pg/L, a value too high for the procedure to be realistically adopted for lead screening
projects. The precision could probably have been improved if the samples were not
manually injected.

Additionally, the method involved more than one transfer o f the

blood sample into various flasks, the manual coating o f the graphite tubes with
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molybdenum, and the use o f a calibration curve created by the method o f standard
additions. These procedures are timely and impractical for routine screening procedures.
Subramanian and Meranger suggested a rapid graphite furnace atomic absorption
spectrometric procedure for the determination o f lead in heparinized human whole blood
using a slightly different phosphate salt for matrix modification.(7) In this method, a
known aliquot o f the blood sample was diluted fivefold with an aqueous solution
composed o f diammonium hydrogen phosphate and Triton X-100.

A deuterium arc

background correction system was utilized with a lead electrodeless discharge lamp to
enhance the sensitivity o f the technique. Nitrogen was used as the purge gas.
The most consistent results were obtained for a fivefold dilution o f blood with 5 g
o f (NH 4 )2 HP 0

4

and 5 mL o f Triton X-100 per liter over the range o f charring

temperatures investigated, which was suggested as the matrix modification solution o f
choice for use in the determination o f lead in blood. More specifically, it was postulated
that the NH** cations helped to minimize the matrix interferences from NaCl through the
formation o f the more volatile NH 4 CI species. The temperature program did not include
the use o f temperature ramps and a step to cleanout the HGA was not included as shown
in Table 7.
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Step

Dry
C har
Atomization

Furnace
Tem perature
(°C)
100
700
2300

Ramp
Time
(»)
0
0
0

Hold
(■)
50
30
8

Internal
Gas Flow
(mL/min)
313
313
0

Table 7: T em perature program used for the study done by Subram anian and
M eranger

The detection limit for the proposed procedure was 10 pg/L, with precisions typically
about 6%. The mean recovery o f lead from spiked samples was reported to be 98.7%.
The method was simple with minimal chances for contamination as it did not require the
use o f many labwares and reagents.

The only sample preparation involved was the

fivefold dilution o f the blood with the matrix modification solution, and thus the
procedure lended itself to automation. Finally, the method was rapid enough to complete
one determination every two minutes, and required only microliter volumes o f blood
sample, thus making the method even more attractive for large-scale screening projects.
Granadillo, Navarro and Romero studied the behavior o f lead in electrothermal
absorption spectroscopy with graphite furnace atomization using palladium or phosphatemagnesium induced matrix modification in conjunction with the carbon-reducing effect
achieved by the addition o f citric acid.(23) The matrix modification solution contained
0.5 mg/L o f palladium and 2% m/v citric acid in 0.01 mol/L nitric acid. For comparison
purposes, a matrix modification mixture consisting o f 0.6% m/v NH4H2PO4 and 0.3%
m/v Mg(NC>3 ) 2 in 0.01 mol/L nitric acid was also used.
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Under an oxygen atmosphere, the lead absorption signal for both matrix
modification techniques was shifted later in time than with an inert atmosphere. These
results suggested a carbon dependent mechanism for the reduction o f the atomic
precursor to form lead atoms with the production o f CO. In addition, a simple method for
the determination o f lead by stabilized temperature platform furnace electrothermal
atomic absorption spectroscopy in clinical samples was developed using palladiuminduced matrix modification, citric acid, and an O2 pyrolysis. The temperature program
is given in Table 8.

Step

Dry
Dry II
Char
Atomization
Cleanout

Furnace
Temperature
(°C)
120
250
600
2000
2700

Ramp
Time

Hold

(s)

(s)

5
20
30
0
1

5
10
15
5
1

Internal
Gas Flow
(mL/min)
300
300
300*
0
300

♦Denotes the alternate gas, air.
Table 8: Temperature program used for the study done by Granadillo, Navarro
and Romero

The limit o f detection was 13 pg/L with recoveries ranging from 94 to 104% and
a relative standard deviation o f 2.2%. In addition, the method was reported to be free
from interferences, and it appeared to be reliable and reproducible.
The matrix modification solutions were not combined directly with the sample
specimens in order to prevent the formation o f any precipitate, as this problem had been
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reported with other procedures. A significant amount o f a carbon-containing residue was
deposited in the graphite tube when no alternate gas was used.

These deposits then

increased after consecutive firings until they reached a point at which the optical beam
was obstructed. This problem was too significant to be corrected by the deuterium arc
background correction system, thus, the air pyrolysis was utilized.

This successfully

prevented the build-up o f the obstructing residue and uniformly dispersed the fine
carbonaceous material across the platform. In addition, no significant deterioration o f the
graphite tube was reported because the oxygen reacted preferentially with the organic
material.
The proposed method for the determination o f lead in whole blood was simple
and lended itself to automation, as most systems can be easily programmed to inject the
sample and modifier in sequence, and to automatically switch to the alternate gas at
pyrolysis. However the whole blood was diluted ten-fold and the limit o f detection could
be improved with lesser dilution.
Many o f the aforementioned methods have taken advantage o f a variety o f
combinations o f matrix modifiers, unique temperature programs, extractions and other
sample preparations to enhance the limit o f detection, precision and reproducibility for
the routine determination o f lead in blood. The best results have tended to be associated
with GFAA systems utilizing the Zeeman background correction system; however, these
are high end systems not readily available in many laboratories.

Furthermore,

preliminary studies in our laboratory have indicated that the procedures prescribed for use
with the Zeeman background correction system do not work with the more conventional
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deuterium arc background correction system. In some instances a clean peak was not
attainable at all, and when signals were obtained the precision and reproducibility were
consistently lacking.

Furthermore, there may be other modifier combinations or

temperature variations which could potentially provide a reliable method for routine
determinations with GFAA systems utilizing the more conventional deuterium arc
background correction system.

Thus, the emphasis o f this project was to develop a

rapid, simple, reliable and accurate method for the determination o f lead in blood, using a
more conventional GFAA system, with an enhanced limit o f detection suitable for routine
lead screenings.

Chapter IV:
Experimental Procedures

Labware
All glassware and Nalgene polyethylene containers were detergent washed, rinsed
with deionized water, and soaked in 10% (v/v) HC1 to prevent possible contamination
from lead adsorption onto the container surfaces. A final rinse was then performed with
semiconductor grade deionized water. All volumetric pipettes were soaked overnight in a
high-density polyethylene container filled with 10% (v/v) HC1 and then rinsed with tap
water followed by thorough rinsings with semiconductor grade deionized water.

All

glassware and containers were covered or capped after washings and drying to prevent
any contamination from the laboratory environment.

Reagents and Standards
Fisher “Reagent” grade HC1 was used for the cleaning o f the laboratory
glassware. Fisher “Trace Metal” grade HNO 3 was used for modifier preparation and for
the acid blank calibration solutions.

The certified metal impurity for lead in the

concentrated HNO 3 is 0.4 ppb.
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The semiconductor grade deionized water was produced by first passing
laboratory deionized water through a particulate filter and then through a semiconductor
grade deionizing cartridge. A polybutylene tap was connected directly to the deionizing
system to avoid contamination from the metal spigots. This system produces deionized
water rated at 18 megaohms in resistance.

Acid blanks and deionized water were

periodically checked for contaminations.
Human blood serum and plasma, and pig blood plasma were obtained from the
Sigma Chemical Company as a lyophilized powder. The samples and standards were
diluted in 0.1% (v/v) Triton X-100. Human blood was drawn from Dr. Gary Rice and
stored in a sealed heparinized tube. The whole blood was diluted in 0.5% (v/v) Triton X100. “Electrophoresis Grade” Triton X-100 was obtained from Fisher Scientific and was
subsequently diluted in deionized water. Triton X-100 is a nonionic surfactant with the
formula C 8 H i 7 (C 6 H 4 )(OCH 2 CH2 )xOH and an average molecular weight o f 628 g/mol.
Plasma, serum and blood solutions with known lead concentrations were prepared
by the method o f standard additions. This was done by spiking the diluted organic matrix
with a standard lead solution.

The standard solution was prepared from a commercially

available lead atomic absorption standard from Aldrich with a certified concentration o f
1000 pg/mL, and successive dilutions were made to create working standard solutions o f
500 pg/L and 100 pg/L. The standards were transferred into Nalgene polyethylene bottles
for storage in order to minimize surface adsorption. The blood matrix solution was spiked
with the appropriate amount o f standard in order to produce the desired blood lead
concentration. For example, if 10 ppb blood lead concentration was desired in a blood
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sample that was diluted 1 :1 , the solution would contain

2 0 0

pL o f blood,

2 0 0

pL o f 0 . 1 %

Triton X-100, and 4 pL o f the spike to produce a total lead concentration o f 10 pg/L.
(4pLt*(500pg/U)
200 pL

=

10 pg/L

Matrix Modifiers
Various matrix modifier solutions were prepared over the course o f the study. A
modifier solution containing

0

.2 % w/v NH4H2PO4, 0.5% v/v Triton X-100 and 0.2% v/v

HNO3 was prepared from ammonium dihydrogen phosphate from the Aldrich Chemical

Company that was reported to be 99.9999% pure. Fisher “TraceMetal Grade” HNO3 was
used.

Later in the study, solutions containing 0.2% w/v NH4H2PO4 and 0.05% Mg(NC>3)2

with and without the addition o f 1% v/v HNO3 were also prepared. Magnesium nitrate
hexahydrate, reported to be 99.995+% pure, from the Aldrich Chemical Company was used.
Other variations in these concentrations were investigated over the course o f the study in an
effort to optimize modifier concentrations.
The palladium matrix modification solution was prepared from a palladium nitrate
matrix modifier solution containing 0.2% Pd in 2% HNO 3 by Specpure from Alfa AESAR.
Ten mL o f the original solution, which contained 2000 mg/L, was diluted into the final
solution by adding 84.3 mL deionized water, 5.7 mL o f HNO 3 and 2.0 g o f citric acid. The
citric acid monohydrate powder was obtained from the J.T. Baker Chemical Company, and
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was reported to contain <0.3 ppm Pb. The resulting solution then contained 200 pg/mL Pd,
2% citric acid and 0.01 mol/L o f nitric acid.

Instrumentation
All atomic absorption determinations were made with a Perkin-Elmer Model 1100B
Atomic Absorption Spectrophotometer equipped with an HGA 700 Graphite Furnace. The
AS-70 Autosampler was used for all sample introductions using polycarbonate sampling
cups. A Fisher single element hollow cathode lead lamp was used for the determination o f
lead. The default software choices for the analytical wavelength (283.4 nm) and the lamp
current (10 mA) were used. The bandwidth slit height set on the monochromator was 0.7
nm low; however, a slit width o f 0.2 nm low was also investigated.
A significant aspect o f optimization involved variations in the temperature programs
to provide the most enhanced and reproducible absorption signals. Signals were taken in
triplicate with 2-6 second integration times and a zero second read delay. An internal argon
gas flow o f 300 mL/min was maintained throughout the graphite tube for every step o f the
temperature program except pyrolysis and atomization. An air flow o f 300 mL/min was
used for pyrolysis, and no internal gas flow was used for atomization. An example o f
specific instrument conditions used is provided in Table 9.
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Step

Dry
Char
Atomization
Cleanout

Furnace
Temperature
(°C)
150
1 0 0 0

1650
2700

30

Internal
Gas Flow
(mL/min)
300
300*

0

10

0

1

7

300

Ramp
Time

Hold

0 0

(s)

2 0

2 0

15

* Denotes the alternate gas, air.
Table 9: Example of a specific temperature program

Four point calibration curves were generated from aqueous and plasma standards
using optimized temperature programs. Auto-zero (absorbance set to zero) was measured
using 1% HNO 3 with a deuterium arc continuum background correction system.

Sample Preparation
The serum and plasma samples were obtained in a lyophilized powder form and
reconstituted with 2.0 mL o f deionized water. All serum and plasma samples were kept
refrigerated until used and discarded when clotting was evident. The whole blood sample
was kept at room temperature. Test portions o f the sample and standard blood, plasma
and serum solutions were prepared fresh prior to each series o f runs by diluting the
samples to ratios (ranging from 1:1 to 1:10) in dilute Triton X-100. They were thoroughly
mixed by pumping the pipettes used in transferring them to the sample cups for the AA
autosampler.

Chapter V:
Results and Discussion

This project began with an attempt to reproduce the method used by Parsons and
Slavin (10); however, human blood serum was used instead o f whole blood since the
primary interferences in blood were suspected to be associated with salts in the blood
plasma. A matrix modifier solution containing 0.2% w/v NH 4 H 2 PO 4 , 0.5% v/v Triton X100 and 0.2% v/v HNO 3 was made in accordance with the method, and temperature
programs for the furnace were used as recommended.

The primary difference in

instrumentation was the use o f a continuum source background correction system instead
o f the Zeeman background correction system used by Slavin.
The first problem encountered was the occurrence o f double peaks and signal
suppression on all o f the lead , an example o f which is shown in Figure

6

. The double

peaks may have occurred because the matrix modifier solution was deposited onto the
platform and then the diluted serum sample was automatically deposited on top to limit
the time spent on sample loading. This may have resulted in inadequate mixing and in
the formation o f lead species with different volatilities at the 1900°C atomization
temperature used.
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Figure 6 : Double lead peaks observed using the Slavin method

Parsons and Slavin diluted the blood samples directly with the matrix
modification solution and mixed the samples well with Eppendorf pipettes. When this
technique was used the double peaks disappeared; however, signal quenching due to the
matrix o f the blood serum was encountered. The background may have been sufficiently
high to cause the baseline and signal to be suppressed as shown in Figure 7. Although
the signal is apparent, it is prematurely quenched by background overcompensation. This
may have been due to the instrumentation, since Parsons and Slavin utilized the Zeeman
background correction system which can compensate for background signals more
effectively.
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Figure 7: Overcompensation of background signal observed using the Slavin
method

In an attempt to remove the matrix interferences causing the high background, the
ashing temperature was held for 25 seconds instead o f the

1 0

seconds recommended by

Parsons and Slavin. A significant improvement in the signal was detected, probably
because more o f the interfering species were removed prior to atomization. Lower rates
o f inert gas flow were tried during the atomization step using a blood serum sample
spiked to 5 ppb with an aqueous lead standard. At a 30 mL/min flow, as recommended
by Parsons and Slavin, the average absorbance peak area obtained over three 15 pL
sample injections was 0.025 A-s. This average steadily increased to a maximum o f 0.085
A-s as the inert gas flow was lowered stepwise to 0 mL/min. Although the purge gas
flow was forcing out some o f the matrix interferences, it was also forcing out lead atoms
during the atomization step and thus attenuating the signal.
absorption profiles are shown in Figure 8 .

Examples o f typical
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Figure 8 : Absorbance profiles for 5 ppb spiked serum at 30 mL/min and at 0
mL/min purge gas flow during atomization

In order to improve reproducibility, a new modifier solution was made containing
the original mix o f chemicals without the addition o f nitric acid, as recommended by
Eaton and Holcombe.(18)

This did in fact result in an improved reproducibility;

however, signals from the blood serum samples still were attenuated relative to the
aqueous lead standards.
In addition, a major attenuation in the signal was observed as the sample aliquots
o f a 25 ppb aqueous standard, made up in the dilute modifier solution containing

0

.2 %

w/v NH 4 H 2 PO 4 and 0.5% Triton X-100, were increased from 15 pL to 50 pL for deposit
in the furnace. This certainly should not have occurred as there were no salts or other
species present in the aqueous standards to interfere with the signal. Visual inspection o f
the deposit o f the sample on the platform revealed that the Triton X-100 surfactant was
reducing the surface tension in the aqueous standards to the extent that the larger volumes
were rolling right off o f the L’vov platform, which is capable o f holding up to a 50 pL
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maximum aliquot size.

Aqueous aliquots over 25 pL repeatedly rolled off o f the

platform, resulting in a loss o f signal and reproducibility.

Unfortunately, the 25 p.L

volume limit could not be surpassed using a different surfactant because Triton X-100 is
universally recommended for blood samples to prevent clotting and precipitation.
Although Parsons and Slavin recommended a sample dilution o f 1:10 with the
modifier solution, the limit o f detection could be improved significantly if reproducible
signals could be obtained from serum samples with a lesser dilution. Thus, one serum
sample was diluted 1:10 with the 0.2% w/v NH4H2PO4 and 0.5% v/v Triton X-100 matrix
modification solution and spiked to 5 ppb, and another was diluted 1:1 with the same
modifier solution and also spiked to a 5 ppb lead concentration.
samples diluted

1 :1 0

The signals for the

were well formed and produced a reproducible signal with little

attenuation as shown in Figure 9.

The samples diluted 1:1 were very poor with no

reproducibility as shown in Figure 10. The background signal was markedly higher and
beyond the limits o f instrumental compensation.
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Figure 9: Absorbance profile for 5 ppb spiked serum diluted 1:10, 0 .2 %NH 4 H 2 PO 4
and 0.5% Triton X-100 modifier solution

Figure 10: Absorbance profile for 5 ppb spiked serum diluted 1:1, 0.2% NH 4 H 2 PO 4
and 0.5% Triton X-100 modifier solution

A new approach was undertaken to minimize the dilution ratio required.

The

modifier solution prescribed by Pruszkowska, Camrick and Slavin was prepared in a
manner similar to the previously tested solution in that it contained 0.2% NH 4 H 2 PO 4
with the addition o f 0.05% Mg(NC>3 ) 2 diluted in 1% HNO 3 . Pruszkowska et. al. noted
that the nitric acid was added in order to prevent the precipitation o f magnesium
phosphate. A solution not containing the nitric acid was also prepared. No precipitation
problems were detected.
Pruszkowska, Camrick and Slavin recommended a lower char temperature o f
650°C, as that temperature was sufficiently high to eliminate the background
interferences in their findings. Zeeman background correction was again used. It was
anticipated that a higher char temperature would be necessary in this study, as the
deuterium arc background correction system is not as efficient as the Zeeman. Thus, char
temperatures o f 650°C and 900°C were tested with both the acidified modifier solution
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and the one without, using serum samples diluted 1:10 and 1:1 with 0.2% Triton X-100
and spiked with lead to 5 ppb.
First, the signal produced with the modifier solution containing 0 .2 % NH 4 H 2 PO 4 ,
0.05% Mg(NC>3 ) 2 and 1% HNO 3 was compared with the solution with no acid.

The

650°C char temperature was used with the sample diluted 1:10. Both sets o f signals
proved to be reproducible; however, the signal produced from the sample modified with
the HNC>3 -containing modifier consistently appeared earlier and with a much lower peak
height than that produced from the sample modified with no HNO 3 , as shown in Figure
11. When these conditions were tried with the serum sample diluted 1:1, the results for
both char temperatures and both modifier solutions were very erratic and not at all
reproducible, as shown in Figure 12. Once again the signal suppression caused by the
large background and chemical interferences from the serum constituents was substantial.

T T Hi

Figure 11: Comparison of peak profiles for spiked serum diluted 1:10 using 650°C
char temperature and modifiers with and without HNO 3
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Figure 12: Absorbance profile for spiked serum diluted 1:1 using 650°C char
temperature and HNC>3 -containing modifier

Next, both modification solutions were tried with both sample dilutions using the
900°C char temperature. As was expected, the signals for the samples diluted 1:10 were
higher with the higher char temperature, as more o f the matrix interferences were burned
out o f the sample prior to atomization. The signals from both modifier combinations
were identical. A signal produced from the acidless modifier is shown in Figure 13. The
signal profiles were similar to those obtained at the 650°C char, and repeated runs proved
the technique to be reproducible when using the modifier without the nitric acid. Thus, it
was determined that the higher char temperature was more effective when using this type
o f procedure.

The signals for the samples diluted 1:1, however, were essentially

unchanged from those obtained when using the 650°C char.

Figure 13: Peak profile for spiked serum diluted 1:10 using 900°C char
temperature and H N 0 3-less modifier

An atomization ramp time was added to the temperature program prescribed by
Pruszkowska, Camrick and Slavin. Samples were diluted 1:1 directly with the acidless
modifier solution with an increase to 0.5% Triton X-100 in addition to the original 0.2%
NH 4 H 2 PO 4 and 0.05% M g(N 03)2 modifiers. Initially, the char temperature o f 650°C was
used with the atomization temperature o f 1700°C; however, the resulting 5 ppb signals
were split and were very erratic regardless o f the atomization ramp time selected. When
the 900°C char temperature was tested, however, the results were more decipherable but
two peaks were always present when an atomization ramp was included in the
temperature program. Furthermore, as the atomization ramp time was increased, the area
o f the first peak steadily decreased and the second peak steadily appeared earlier in time.
Figure 14 shows a comparison o f the peak profiles when the sample was atomized at a
temperature o f 1700°C with a ramp o f one second and with a ramp o f three seconds.
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Once again, there appears to be more than one lead species present with varying
volatilities after the charring stage.
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Figure 14: Comparison of profiles for spiked serum diluted 1:1 with an atomization
ramp of 1 and 3 sec

The signals were then compared to the signal o f an aqueous standard that was
diluted 1:1 with the same modifier solution (less the Triton X-100) and spiked with lead
to 5 ppb. It was discovered that the second peak o f the serum sample signal closely
matched the signal profile o f the aqueous standard with respect to time o f elution as
depicted in Figure 15. Thus, it was assumed that the second peak o f the serum sample
signal was representative o f the lead species normally produced, and that the first peak
was due to a more volatile secondary species produced in the char from unknown
reactions or interactions.

Figure 15: Aqueous standard with an atomization ramp of 3 seconds

Table 10 contains a summary o f the instrumental parameters and matrix modifiers
used at this stage o f the investigation. The goal was to further modify the instrumental
parameters in order to eliminate the first peak while keeping the sample dilution ratio at
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Step

Dry
Dry II
C har
Atomization
Cleanout

Furnace
Tem perature
(°C)
130
260
900
1900
2500

Ramp
Time
(s)
5
5
1
3
1

Hold
(s)
45
10
5
5
2

Internal
Gas Flow
(mL/min)
300
300
300
0
300

M odifier Solution: 0.2%NH4H2PC>4
0.5% M g(N 03)2
0.5% Triton X-100
Table 10: Revised procedural conditions

As suggested by Granadillo, Navarro and Romero, the slit bandpass through
which the light sources must pass was reduced from a width o f 0.7 nm to a width o f 0.2
nm in an effort to decrease the background absorption.(23) Because this smaller slit
width allows less source light to pass through while the electronic noise remains constant,
it was anticipated that the signals might display more noise than those measured with a
slit width o f 0.7 nm. This was proven to be true. The background signal was reduced a
bit with the lower 0.2 nm slit width; however, the signals obtained at the 0.7 nm slit width
were far more reproducible.
The project continued with the use o f a completely different modification solution
containing 0.5 mg/L Pd and 2% m/v citric acid in 0.01 mol/L nitric acid, as suggested by
Granadillo, Navarro and Romero.(23)

In addition, the purge gas was switched from

argon to air during the pyrolysis step, in an effort to improve the combustion o f the
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organic matrix. The temperature programs and instrumental parameters prescribed by
their work were replicated using a bandpass o f 0.7 nm. Precipitation problems were
anticipated, so the serum samples were diluted 1:10, 1:4 and 1:1 with 0.1% v/v Triton X100 and spiked with lead to 5 ppb. The samples and modifiers were dropped onto the
platform sequentially instead o f being pre-mixed and dropped onto the platform in one
shot. For each o f these dilution ratios the signal profiles were similar and double peaks
were apparent, as seen in Figure 16 for a serum sample diluted 1:9 and modified with the
0.5 mg/L palladium solution. In order to solve this problem, variations in the atomization
ramp time were tried for the 1:10 dilutions.

Figure 16: Absorbance profile for 5 ppb serum diluted 1:10, modified with 0.5 mg/L
Pd and 2% citric acid in 0.01 moI/L H N 03

When an atomization ramp o f one second was added to the temperature program,
the first peak was significantly reduced and the overall peak area was only slightly
reduced as seen in Figure 17. The two second atomization ramp produced a single peak
for the samples diluted 1:10; however, the profile appeared later in time and the peak area
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was significantly reduced. Figure 18 shows a comparison o f the peak profiles with no
atomization ramp and with a two second ramp. Finally, the three second atomization
ramp produced peak profiles for the samples diluted 1:10 that appeared even later than
those at the two second ramp; however, the profiles were essentially the same shape. The
three second ramp also eliminated the first peak for the samples diluted 1:4; however, the
signals were very noisy and not very reproducible.

/

Figure 17: Profile for serum diluted 1:10, using 1 sec atomization ramp

Figure 18: Comparison o f profiles using 0 and 2 sec atomization ramp times
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In order to further improve the signal, a greater concentration o f palladium was
added to the modifier. Higher palladium concentrations are typically used for samples
containing high salt concentrations.

Earlier attempts to run samples with Pd

concentrations in the 0.1-1% range resulted in massive precipitation in the serum
samples. Thus, a more gradual increase in the Pd levels was investigated.
A new modifier solution containing 5 mg/L Pd and 2% m/v citric acid in 0.01
mol/L nitric acid was produced. The resulting lead signals from spiked serum samples
were larger and more reproducible, and the first peak disappeared. However, the high
background signal was causing the baseline to bottom out.

Figure 19 contains a

comparison o f the profiles from 1:4 dilutions using both palladium concentrations; 0.5
mg/L and 5 mg/L. Higher atomization temperatures of 1800°C and 1900°C were tried in
an effort to resolve the problem but they produced no appreciable effects.

ri,

iC.

Figure 19: Comparison of profiles for 1:4 using both modifiers,
0.5 mg/L Pd and 5 mg/L Pd

As was expected, when the atomization ramp was altered to two seconds with the
original atomization temperature o f 2000°C the background signal appeared earlier but
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further attenuated the signal, as seen in Figure 20.

When the atomization ramp was

increased to four seconds the background should have appeared later; however, two
background peaks were produced which attenuated the signal early on, as seen in Figure
21. There are apparently numerous species present in the matrix which have significant
temperature dependencies with respect to the time frame associated with volatilization.
Thus, the atomization temperature remained at the recommended 2000°C with a ramp o f
3 seconds for further experimentation with modifiers containing higher palladium
concentrations.
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Figure 20: Peak profile from 2 sec atomization ramp times
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Figure 21: Peak profile from 4 sec atomization ramp times

A modifier solution containing 50 mg/L Pd and 2% citric acid in 0.01 mol/L nitric
acid was then evaluated.

This combination produced signal profiles for the serum

samples diluted 1:4 that were much more gaussian in peak shape. A comparison o f the
signals produced using the modifiers containing 5 mg/L Pd and 50 mg/L Pd is shown in
Figure 22.

Note that the signal for the 50 mg/L Pd sample appears longer into the

atomization time, implying that additional levels o f Pd are stabilizing the Pb species with
respect to volatilization and atomization temperatures.
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Figure 22: Comparison of signals produced using the modifiers
containing 5 mg/L Pd and 50 mg/L Pd

In an attempt to further improve the reproducibility and peak profiles, modifier
solutions containing the 2% citric acid in 0.01 mol/L nitric acid with various Pd
concentrations were evaluated. Modifier solutions were prepared containing 100 mg/L
Pd, 200mg/L Pd, 300 mg/L Pd and 500 mg/L Pd. All modifier concentrations were then
tested with the furnace conditions prescribed by Granadillo, Navarro and Romero, and
with the recommended slit bandpass o f 0.2 nm.
The smaller slit width produced signal profiles that were much more noisy, as
expected. As the lead concentrations in the modifier were increased from 50 mg/L to 500
mg/L, some signal was lost and the profiles broadened. Figure 23 shows a comparison o f
the signals for 1:4 dilutions with 100 and 300 mg/L Pd in the modifier. At the 500 mg/L
Pd concentration some background overcompensation was apparent and the signals were
prematurely quenched. The signals were most reproducible at the middle o f the range o f
Pd concentrations, in particular from 100 mg/L to 300 mg/L Pd. For the first time in this
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project, the signals for samples diluted 1:1 were discernible; however, reproducibility
was very poor. In addition, as the dilution ratio was lessened from 1:4 to 1:1 using the
same modifier solution, some o f the signal was lost and the samples diluted 1:1 appeared
later than those diluted 1:4. Figure 24 provides a comparison. It was postulated that
species in the matrix were decelerating the atomization of the less dilute samples,
possibly due to increased residues on the graphite surface which provided for poorer
contact o f the lead at the graphite surface during atomization. Thus, the hold time on the
char and the atomization temperatures were increased.

Figure 23: Comparison of profiles for samples diluted 1:4, modifiers
with 100 mg/L Pd and with 300 mg/L Pd
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Figure 24: Comparison of profiles for samples diluted 1:4 and 1:1 using
modifier with 100 mg/L Pd

Continued improvements in the method from this point made use o f pig and
human plasma instead o f serum, which is a matrix closer to whole blood less the cell
content. To ensure that this new matrix did not produce any appreciable differences in
the signals, the previously tested conditions were used and the signals were essentially
unchanged. Next, the char ramp was decreased to 15 seconds and the char hold increased
to 30 seconds using the prescribed char temperature o f 600°C.

Furthermore, the

atomization ramp time was increased to 3 seconds, and the hold was increased to 10
seconds at the prescribed temperature o f 2000°C. The modifier containing 100 mg/L Pd
was used. Unfortunately, the peak profile was significantly changed and double peaks
appeared with a quenching apparent between the two.

Similar profiles were obtained

when the atomization temperature was increased to 2100°C and then to 2200°C. When
the modifier containing 200 mg/L Pd was used, the double peaks persisted and the first
peak height decreased as the second peak height increased; however, both peak areas
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appeared to increase as shown in Figure 25. All variations in atomization temperature
produced similar results, and as the char temperature was increased both peak heights
decreased. When the Pd concentration in the modifier was increased to 500 mg/L, triple
peaks appeared and more peaks may have existed after the integration time cut the signal
off.

Figure 25: Comparison o f peak profiles using modifiers with 100 mg/L Pd
and 200 mg/L Pd

When the originally prescribed conditions were tried again using the modifier
containing 100 mg/L Pd, the second peak persisted and the profile was essentially the
same. It was postulated that perhaps an absorptive buildup in the tube was causing the
additional peaks, and dry fire runs revealed small peaks o f residue. Thus, the hold on the
cleanout step was increased to five seconds.

In addition, runs o f just the modifiers

containing 100 mg/L Pd and 200 mg/L Pd both revealed numerous peaks, and it was
determined that a lead contamination to the modifiers was contributing to the problem.
Thus, the graphite tube was changed and new modifiers were produced.
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Experimentation resumed with the temperature program using the increased hold
times on the char and atomization steps.

The temperature program developed to this

point is summarized in Table 11. The peak profile for the plasma sample diluted 1:4
using the modifier containing 50 mg/L Pd was clean with only a trace o f a second peak.
The palladium certainly had an impact on the signals; however, because as the Pd
concentration was increased the second peak began to grow and the first peak began to
spread out. Figure 26 shows a comparison o f the modifiers containing 50 mg/L Pd and
200 mg/L Pd. It was speculated that as the palladium concentration increased, the chance
for a matrix-Pd precipitation also increased since Pd significantly enhances precipitation
o f species in serum and plasma. Thus, the first peak was due to the free Pb, and the
second was due to some precipitate that required more time to volatilize in the
atomization stage. In an attempt to prevent precipitation, the order in which the modifier
and the sample were deposited onto the platform was reversed with the modifier being
deposited first. This, however, did not produce an appreciable difference in the signal
profiles.

Step

Dry
Dry II
Char
Atomization
Cleanout

Furnace
Temperature
(°C)
120
250
600
2000
2700

Ramp
Time
(s)
5
20
15
0
1

Hold
(s)
5
10
30
10
5

*Denotes the alternate gas, air.
Table 11: Modified temperature program for use with Pd method

Internal
Gas Flow
(mL/min)
300
300
300*
0
300
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Figure 26: Comparison of peak profiles using modifiers with 50 mg/L Pd
and 200 mg/L Pd

At this point in time, the GFAAS system was overhauled. This consisted o f a
thorough cleaning o f the furnace, replacement o f the contacts and installation o f a new
graphite tube.

When the different modifiers were again compared using the plasma

diluted 1:4, the second peak again appeared as the concentration o f Pd was increased, and
the first peak again broadened. In addition, a slight attenuation o f the signal was detected
with the growth o f the second peak. The modifier containing 200 mg/L Pd appeared to
be most reproducible without creating a significant second peak, thus it was used for
experimentation throughout the remainder o f the project.
As the dilution ratio was lessened from 1:4 to 1:3, the first peak narrowed and the
second peak again grew; however, the overall peak height remained relatively constant as
seen in Figure 27. As the samples became less dilute, a lead-containing species was
being retained longer relative to the majority o f the lead, which was more easily
volatilized. It was speculated that a small amount o f lead might have been imbedded in
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the charred material and thus retained, or the two peaks may have been the result o f
sample splattering during the dry. If the sample was present in two different areas o f the
tube, two peaks may have resulted due to temperature variations along the length o f the
tube.

Figure 27: Comparison of peak profiles for plasma diluted 1:4 and 1:3, modifier
containing 200 mg/L Pd

The temperature program that had been used at this point consisted o f two dry
steps. As the program advanced from one dry to the next, a quiet sizzle was heard. Thus,
it was determined that sample spattering did in fact contribute to the double peak
problem. In an attempt to reduce possible sample splattering the first dry temperature
was increased from 120°C to 150°C with the ramp increased from 5 seconds to 20
seconds and the hold increased from 5 seconds to 20 seconds. The second dry step was
eliminated.

No spattering was heard with the incorporation o f the revised drying

temperature program. Sample spattering apparently was not the only contributor to the
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double peak problem because the problem worsened with increased Pd concentrations
and with lower dilution ratios.
The char temperature was next evaluated from 600°C to 1100°C in 100°C
increments.

The second peak height significantly decreased until it eventually

disappeared as the char temperature was increased. Figure 28 shows a comparison o f the
profiles for the plasma samples diluted 1:4 using char temperatures o f 700°C and 1000°C.
The revised drying temperature, used in conjunction with the increased char temperature
o f 1000°C, produced clean signals with comparable peak heights and areas for samples
diluted as low as 1:3. When these conditions were tried using plasma samples diluted at
1:2 the second peak reappeared.

However, when the char temperature was further

increased to a temperature o f 1100°C, the second peak disappeared, the signals were
gaussian and reproducible, and the peak areas and heights were comparable to those o f
the more dilute samples. Figure 29 shows a comparison o f the plasma samples diluted
1:2 using the revised dry conditions and char temperatures o f 1000°C and 1100°C.

Figure 28: Comparison of peak profiles for plasma diluted 1:4 using
char temperatures of 700°C and 1000°C

Figure 29: Comparison of peak profiles for plasma diluted 1:2 using char
temperatures of 1000°C and 1100°C

Next, the char temperature was held at 1100°C as the atomization temperature
varied, in an attempt to optimize the atomization temperature. A slit bandpass o f 0.7 nm
was used. The plasma samples diluted 1:2 were spiked with lead to 30 ppb, in order to
increase the signals and facilitate the experimentation.

In addition, the signals were

electronically magnified by a factor o f ten so that additional digits could be evaluated
when examining signal reproducibility. As the atomization temperature was decreased
from 2000°C, as was originally prescribed by Granadillo, Navarro and Romero, all the
way down to an atomization temperature o f 1500°C , the peak areas steadily increased,
the profiles were essentially unchanged and the reproducibility o f the measurements was
good. When the atomization temperature was further decreased to 1400°C, the peak
areas continued to increase but the peak profile spread out across the entire integration
time. Figure 30 shows for a comparison o f the peak profiles at various atomization
temperatures with the char held constant at 1100°C. At an atomization temperature o f
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1300°C the signal was significantly decreased, implying that an insufficient temperature
was obtained to atomize Pb from the sample.

Figure 30: Comparison of profiles for various atomization temperatures with a
char of 1000°C using plasma diluted 1:2

When these temperature changes were tried with aqueous samples spiked to 30
ppb the optimum atomization temperature and the peak profiles were markedly different.
The profiles appeared a little later than those o f the plasma samples, the peak heights
were significantly lower, and the peak areas were lower as well.

When the char

temperature was held constant at 1000°C the peak areas increased as the atomization
temperature was lowered from 2000°C to 1700°C; however, the peaks broadened and the
heights decreased. At 1600°C and below the peak areas also began to decrease and a
small, early-running peak was apparent.

Figures 31 and 32 provide profiles for the

aqueous sample at an atomization temperature of2000°C and 1700°C, respectively. Note
that the time scaling on the X-axis is different.

A plot o f peak area vs. atomization

temperature for blood plasma and aqueous standards is given in Figure 33. The points
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represent the average peak area for the runs done in triplicate.

The relative standard

deviations for these points ranged from 0.64% -3.5% for the plasma; however, the
relative standard deviation for the point at 1300°C was 20%, as the results were not very
reproducible at this atomization temperature. The relative standard deviations for the
aqueous samples ranged from 0.33% to 1.6%, except for the atomization temperature o f
1400°C.

The relative standard deviation at this point was 18.4%, again because the

results were not very reproducible at this temperature. An interesting result o f this study
was that although the optimum atomization temperatures are significantly different for
the blood plasma and aqueous standards, the intermediate temperatures o f about 1650°C
and 1800°C provide an overlap where the net absorbance o f both is comparable.

Figure 31: Profile for a 30 ppb aqueous sample with the char at 1100°C and the
atomization at 2000°C

Figure 32: Profile for a 30 ppb aqueous sample with the char at 1000°C and
the atomization at 1700°C

Figure 33: Optimization of atomization temperatures for both aqueous and
plasma samples

Optimization of Atomization Temperatures
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The char temperature was reevaluated using the plasma samples. The atomization
temperature was held constant at 1500°C, as this temperature produced the best results for
the plasma. At a char o f 1200°C, a clean gaussian peak was obtained, and numerous
replicates proved this temperature to be reproducible.

As the char temperature was

decreased to 1100°C the profile was similar and reproducibility was still good. As the
char temperature was lowered even further, stepwise down to 800°C, the peak areas
significantly decreased, the background significantly increased, the peak profiles spread
out and the peaks appeared later with lower reproducibility.

Figure 34 shows a

comparison o f these profiles and Figure 35 a graphical interpretation of these results.
The points represent the average peak area for runs taken in triplicate, and the relative
standard deviations for these points ranged from 0.23% to 4.6%.

j.

~. W
Figure 34: Comparison of profiles for various char temperatures with an
atomization o f 1500°C using plasma diluted 1:2
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Figure 35: Optimization of charring temperatures

Optimization of Charring Temperatures
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An examination o f Figure 33 indicated that at the optimum charring temperature
o f 1000°C, the peak areas for the plasma samples and aqueous samples should be
comparable if an atomization temperature o f about 1650°C, 1800°C or 1900°C was used.
O f these temperatures, 1650°C was closest to the optimal atomization temperature for
blood plasma (about 1400°C-1500°C). Thus, at an atomization o f 1650°C a calibration
curve could theoretically be generated from aqueous standards which would match
signals generated from the blood plasma.
The optimized procedural conditions used up to this point are summarized in
Table 12. A calibration curve was generated from aqueous standards spiked with lead to
give concentrations o f 5, 15, 30 and 50 ppb. Plasma samples were diluted 1:2 and also
spiked to the same concentrations. Figure 36 provides a comparison o f the peak profiles
for both matrices spiked to 30 ppb. The matrix certainly has an effect, as the profiles are
markedly different. The plasma peak appears first, and the aqueous peak is broader with
a lower peak height; however, the overall peak areas are essentially the same. Calibration
curves generated from both matrices are provided in Figure 37. Slopes were generated
from a linear regression fit using Excel. The slope for the aqueous standards was .0021,
and that for the plasma samples was .0022. The similarities imply that the matrix effects
are minimal if peak areas, instead o f peak heights, are considered.
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Step

Dry
Char
Atomization
Cleanout

Furnace
Temperature
(°C)
150
1000
1650
2700

Ramp
Time
(s)
20
15
0
1

Hold

Internal
Gas Flow
(mL/min)
300
300*
0
300

(s)
20
30
5
5

♦Alternate gas, air
Modifier Solution:

200 mg/L Pd and
2% w/v Citric Acid in
0.01 mol/L Nitric Acid
Plasma Sample Dilution: 1:2 with 0.1 % v/v Triton X -100
Table 12: Optimized procedural conditions for plasma

TIME ( SE C)

3.5

Figure 36: Comparison of peak profiles for both matrices spiked to 30 ppb

Figure 37: Calibration curves for plasma

Calibration Curves
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Next, a whole blood sample was diluted 1:2 with 0.1% v/v Triton X-100, spiked
with lead to 30 ppb and run under the same instrumental parameters. Initially, the blood
samples did not drop directly onto the L’vov platform but instead climbed up the sides o f
the graphite tube due to high surface tension. Thus, blood samples were diluted with a
greater concentration o f Triton X-100 surfactant (0.5% v/v). This solved the problem and
peak profiles were obtained; however, the peak areas were only about 60% o f the
expected value. Thus, the char temperature was increased from 1000°C to 1100°C in an
effort to increase the signal; however, all signal was lost. Next, a char temperature o f
1050°C was used and only a hint o f a peak was apparent. When the char temperature was
lowered to 900°C, the peak areas were equal to those o f aqueous standards run with the
same temperature program.
Using the 900°C char temperature, the peak profiles for the blood samples were
sharper than those o f the plasma samples, and they also appeared earlier in time.

In

addition, the plasma samples gave absorbance peak areas that were erroneously high
when compared to the signals for the aqueous standards. Figure 38 shows a peak profiles
for plasma, and Figure 39 shows one for blood.

This comparison indicates that the

organic load has a substantial impact on the lead volatility and atomization rate.
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0

Figure 38: Peak profile for 30 ppb plasma sample diluted 1:2

3,0

Figure 39: Peak profile for 30 ppb whole blood sample diluted 1:2

Analytical signals from the blood samples were very reproducible. For five runs
o f the sample spiked with lead to 30 ppb, an average peak area o f 0.0846 A-s was
obtained with a relative standard deviation o f 4.3%. An unspiked blood sample which
was run five times gave an average peak area o f 0.0098 A-s with a relative standard
deviation o f 0.92%. Based on Beer’s law, if a signal for 30 ppb gave a reproducible
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average peak area o f 0.0846 A-s; a reproducible average peak area o f 0.0098 would
represent a signal o f about 3.4 ppb. As the unspiked blood samples gave very clean and
reproducible peak profiles with an average peak area o f 0.0098, it can be estimated that
the limit o f detection associated with this method is in the 0.5-1 ppb range. The final
temperature program and matrix modifiers used to obtain these results are provided in
Table 13.

Step

Dry
Char
Atomization
Cleanout

Furnace
Temperature
(°C)
150
900
1650
2700

Ramp
Time
(s)
20
15
0
1

Hold
(s)
20
30
5
7

Internal
Gas Flow
(mL/min)
300
300*
0
300

♦Alternate gas, air
Modifier Solution:

200 mg/L Pd and
2% w/v Citric Acid in
0.01 mol/L Nitric Acid
Plasma Sample Dilution: 1:2 with 0.5% v/v Triton X-100
Table 13: Optimized procedural conditions for blood

A calibration curve was generated from aqueous standards spiked with lead to
give concentrations o f 5,15,30 and 50 ppb. Blood samples were diluted 1:2 with the
0.5% v/v Triton X-100 and also spiked to the same concentrations. The resulting curves
are provided in Figure 40. Slopes were again generated from a linear regression fit using
Excel. The slope for the aqueous standards was 0.0018, and that for the blood samples
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was 0.0010.

Although the aqueous curve is a little higher than the blood curve, the

similarities again imply that the matrix effects are insignificant if peak area, instead o f
peak heights, are considered. Time did not allow for further refinements in the method.

(s-v) eejv >*Bad-aouBqjosqv

Figure 40: Calibration curves for whole blood
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An explanation for this difference in the peak profiles can be derived from an
explanation o f the atomization mechanism postulated by Granadillo, Navarro and
Romero.(23)

The mechanisms by which palladium actually interacts with the lead

analyte are still being debated.

However, it is apparent that any model intended to

elucidate the atomization mechanism must consider the following circumstances: (1) the
type o f chemical and/or physical interactions existing between the graphite surface, the
analytical matrix modifier and the analyte; (2) the reductive capability o f the carbon at
the high operating temperatures o f the ETAAS technique; and (3) the availability o f
active carbons within the graphite furnace to reduce the atomic precursor to the analyte
atoms.

Thus, Granadillo, Navarro and Romero considered the effects that increasing

amounts o f potentially reducing carbon, produced by the addition o f carbon-containing
compounds to the samples, exerted on the absorbance-time profiles of lead atomized in
the graphite furnace.

In addition, the reductive action o f the carbon in the graphite

furnace itself was considered.
Several researchers have established that the graphite surface plays a major role
in the atomization o f any metal in GFAAS.(12,16,17) The graphite surface consists o f
crystallites o f graphite with carbon atoms lying in a basal plane which is terminated by
carbons in zigzag and armchair configurations.(23) These edge carbons constitute the
active surface area o f the graphite because they have unpaired a-electrons available to
form bonds, whereas the basal plane carbons have their a-electrons tied up in bonds with
the adjacent carbons.
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Previous work has indicated that the use o f reducing agents to promote the
reduction o f palladium is essential to obtain the modification effect.(23) In this study, the
citric acid was utilized for this purpose to create a better reducing environment by
providing active carbon sites different from those found on the graphite furnace. Thus, in
the presence o f the citric acid, the carbon sites o f the furnace were less susceptible to
oxidation and the lifetime o f the graphite structure was prolonged.
When no citric acid was added to either the aqueous or blood samples they
discovered that the fastest lead atomization occurred in the blood samples due to the high
organic content.(23)

Apparently, an additional supply o f reducing carbons, different

from those provided by the graphite furnace, were available from the carbonaceous
matrix. However, when 200 pg o f citric acid was added to both the aqueous and blood
samples, the lead profiles appeared at the same early time.

Furthermore, this

phenomenon occurred with the exact same profile appearance time for both the palladium
modification solution and also for a phosphate-magnesium modification solution.
These results suggested that the atomization rate o f lead was independent o f the
matrix and o f the modifier used, and that a carbon-dependent mechanism occurred.(23)
The differences in the plasma and blood peak profiles provided in Figures 38 and 39
added further credence to this theory.

The blood samples, which contained a higher

carbonaceous load, appeared much earlier than the plasma samples.
Granadillo, Navarro and Romero proposed the following mechanisms for the
atomization o f lead by GFAAS with palladium modification [equations (1) and (2)] and
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with magnesium-phosphate modification [equations (3) through (5)], assuming that a
carbon source other than the graphite surface was available.(23)

*-Pd-PbO —►PbO

(1)

PbO + C

(2)

Pb + CO

and

*-Pb2P20 7 -► Pb2P20 7

Pb2P20 7 + 2C

P20 3 + 2PbO + 2CO

2PbO + 2C -> 2Pb + 2CO

(3)

(4)

(5)

* denotes carbon surface o f graphite tube

The intermediate species, such as PbO and Pb2P20 7, were not identified in this
study due to a lack o f instrumental facilities; however, further experimentation added
credence to the postulated atomization mechanism.(23)

The redox reaction between

Pb2P20 7 and 2 mol o f carbon atoms, as postulated, would result in the formation o f 1 mol
o f P20 3, 2 mol o f PbO and 2 mol o f CO. A further 2 mol o f carbon would then be
required for the reduction o f the 2 mol o f PbO to form 2 mol o f Pb atoms and 2 mol o f
CO.Therefore,

4mol o f carbon atoms would beneeded

occurred aswritten.

for theover-allreaction if it

This was verified experimentally when four times more

mass of
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citric acid was needed to reduce the phosphate-magnesium modification than for the
palladium modification technique, with the same appearance time for the analyses o f the
samples and aqueous standards.
Additional support for the proposed mechanism was obtained when atomization
was attempted under a partial pressure o f CO, and it was discovered that the absorbance
profiles for both standards and samples appeared later in time.(23) It was postulated that
the time shift in the appearance o f the absorption pulse occurred as a result o f a
suppression o f the redox reaction that produced atomic lead, as described by equation (2),
in response to the increase in the partial pressure o f CO.

The carbon monoxide

atmosphere caused the system at equilibrium to shift to the reactant side.
In conclusion, the proposed carbon-induced reduction o f the atomic precursor
may be the mechanism to occur for any analyte that undergoes atomization via the
oxide.(23) However experimental verification, such as by GFAAS-mass spectrometry, o f
the existence o f the postulated intermediates in the graphite furnace is required to further
substantiate this atomization mechanism o f lead.

Chapter VI: Summary

The use o f GFAAS for the determination o f lead in blood has increased
significantly in the past decade.(18) Most o f the published methods utilize the Zeeman
background correction system; however, this system is not readily available in many
testing laboratories and the methodology utilized was found not to be effective with a
more conventional deuterium arc background correction system.

This led to the

development o f refined matrix modification and atomization procedures which gave a
good reproducibility and sensitivity, and also a good linear range o f determination for
lead in blood. The limits o f detection in particular were significantly improved by a
factor o f about ten over values reported in the literature by reducing the dilution ratio
necessary for the blood analysis.
Work with whole blood samples was only performed over the very last stages o f
this project, thus there are several parameters that need to be addressed and refined. In
particular, an optimization o f the furnace and temperature conditions such that all signals
are equivalent regardless o f whether the samples are aqueous, plasma or whole blood
would be very beneficial. In addition, further verification o f the reproducibility needs to
be addressed in particular with the whole blood samples at low concentrations (<10 ppb).
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Finally, the complete linear working range for lead concentrations in blood must be
determined.
Reproduciblity will be a crucial consideration based on the CDC requirement that
clinical decisions be made for children whose blood Pb level is above 150 ppb.

For

instance, suppose a physician is monitoring a child whose true BPb is at a dangerous
level o f 170 ppb. The blood analyses at two laboratories both work with reproducibilities
within an accepted + or - 20 ppb limit. The physician may face a situation where one
laboratory returns a result o f 150 ppb, which may not require intervention, and the other
returns a 190 ppb result, which would require intervention. Clearly, the burden on public
health officials would be lessened if laboratories could operate within a +/- 1-5 ppb limit
at low levels. The method described by this work appears to have good reproducibility as
referenced by the relative standard deviation o f 4.3% for 30 ppb blood samples. This
standard deviation is clearly reproducible enough to give good clinical reliability;
however, continued refinements to the methodology may be necessary for accurate
quantification and use in large scale screening programs.
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